Sales Representative

Veryan Medical is seeking a Principal Account Manager to drive growth within the peripheral vascular and endovascular market. This role focuses on developing new business, expanding existing accounts, and increasing physician adoption of the BioMimics-3D Stent and REVOLUTION Atherectomy platforms. The ideal candidate will have 3+ years of vascular or endovascular medical device sales experience, strong relationships with Vascular Surgeons, Interventional Cardiologists, and Interventional Radiologists, and experience selling into hospital-based procedural environments. Success in navigating value analysis, growing market share, and exceeding quota is essential. This is a high-autonomy opportunity with a growth-stage commercial team backed by Otsuka Medical Devices Group, offering strong earnings potential and future leadership opportunities.

Differentiated Products – Sell innovative vascular technologies including BioMimics-3D and REVOLUTION.
Growth Opportunity – Join a rapidly expanding commercial team with future leadership potential.
Backed by Otsuka – Startup-like culture with the stability of a global healthcare organization.
High Autonomy – Make a direct impact on territory growth and physician adoption.
Strong Compensation – Competitive base salary with uncapped earning potential.


The ideal candidate is a successful vascular or endovascular medical device sales professional with 3+ years of experience selling into hospital-based procedural environments. They are actively supporting cases, maintain strong relationships with Vascular Surgeons, Interventional Cardiologists, and Interventional Radiologists, and have experience with stents, atherectomy, thrombectomy, or related PAD technologies.
This individual has a proven track record of exceeding quota, navigating value analysis and hospital contracting processes, and driving both new business development and existing account growth. They thrive in a high-autonomy, growth-oriented environment and can make an immediate impact with minimal oversight.